215 related articles for article (PubMed ID: 26701102)
1. Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma.
Yang SM; Huang CY; Shiue HS; Huang SP; Pu YS; Chen WJ; Lin YC; Hsueh YM
PLoS One; 2015; 10(12):e0145410. PubMed ID: 26701102
[TBL] [Abstract][Full Text] [Related]
2. The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Lin YC; Chen WJ; Huang CY; Shiue HS; Pu YS; Chen CH; Su CT
Toxicol Appl Pharmacol; 2017 Oct; 332():1-7. PubMed ID: 28733204
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
[TBL] [Abstract][Full Text] [Related]
4. Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study.
Shen BL; Qu QS; Miao SZ; Zhang YX
Genet Mol Res; 2015 Sep; 14(3):11119-25. PubMed ID: 26400342
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma.
Chung CJ; Bao BY; Lin YC; Huang YL; Shiue HS; Ao PL; Pu YS; Huang CY; Hsueh YM
Sci Rep; 2020 Apr; 10(1):6640. PubMed ID: 32313131
[TBL] [Abstract][Full Text] [Related]
6. The joint effects of arsenic and risk diplotypes of insulin-like growth factor binding protein-3 in renal cell carcinoma.
Huang CY; Huang YL; Pu YS; Shiue HS; Chen WJ; Chen SS; Lin YC; Su CT; Hsueh YM
Chemosphere; 2016 Jul; 154():90-98. PubMed ID: 27038904
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas.
Xian W; Zheng H; Wu WJ
Genet Mol Res; 2015 Jul; 14(3):7634-42. PubMed ID: 26214443
[TBL] [Abstract][Full Text] [Related]
8. VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population.
Sáenz-López P; Vazquez F; Cozar JM; Carretero R; Garrido F; Ruiz-Cabello F
Hum Immunol; 2013 Jan; 74(1):98-103. PubMed ID: 23073296
[TBL] [Abstract][Full Text] [Related]
9. The polymorphisms of P53 codon 72 and MDM2 SNP309 and renal cell carcinoma risk in a low arsenic exposure area.
Huang CY; Su CT; Chu JS; Huang SP; Pu YS; Yang HY; Chung CJ; Wu CC; Hsueh YM
Toxicol Appl Pharmacol; 2011 Dec; 257(3):349-55. PubMed ID: 21982800
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor gene polymorphisms and the risk of renal cell carcinoma: Evidence from eight case-control studies.
Gong M; Dong W; Shi Z; Qiu S; Yuan R
Oncotarget; 2017 Jan; 8(5):8447-8458. PubMed ID: 28039484
[TBL] [Abstract][Full Text] [Related]
11. Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis.
Tang J; Qin Z; Li X; Han P; Wang F; Yang C; Li R; Wang K; Tang M; Wang W; Lv Q; Zhang W
Oncotarget; 2017 Jul; 8(30):50034-50050. PubMed ID: 28489583
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Chen WJ; Lin YC; Huang CY; Shiue HS; Yang SM; Ao PL; Pu YS; Su CT
Toxicol Appl Pharmacol; 2018 Jul; 350():11-20. PubMed ID: 29723618
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case-control study.
Lu G; Dong Y; Zhang Q; Jiao L; Yang S; Shen B
Tumour Biol; 2015 Nov; 36(11):8645-52. PubMed ID: 26044558
[TBL] [Abstract][Full Text] [Related]
14. Predictive role of vascular endothelial growth factor polymorphisms in the survival of renal cell carcinoma patients.
Yang YQ; Chen J
Genet Mol Res; 2014 Jul; 13(3):5011-7. PubMed ID: 25062489
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressiveness.
Sa-Nguanraksa D; Chuangsuwanich T; Pongpruttipan T; Kummalue T; Rojananin S; Ratanawichhitrasin A; Prasarttong-Osoth P; Chuthatisith S; Pisarnturakit P; Aeumrithaicharoenchok W; Rushatamukayanunt P; Lohsiriwat V; Boonsripitayanon M; Malasit P; O-Charoenrat P
Mol Med Rep; 2013 Oct; 8(4):1242-50. PubMed ID: 23904001
[TBL] [Abstract][Full Text] [Related]
16. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
[TBL] [Abstract][Full Text] [Related]
17. Urinary total arsenic and 8-hydroxydeoxyguanosine are associated with renal cell carcinoma in an area without obvious arsenic exposure.
Huang CY; Su CT; Chung CJ; Pu YS; Chu JS; Yang HY; Wu CC; Hsueh YM
Toxicol Appl Pharmacol; 2012 Aug; 262(3):349-54. PubMed ID: 22659136
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin-aldosterone system related gene polymorphisms and urinary total arsenic is related to chronic kidney disease.
Chen WJ; Huang YL; Shiue HS; Chen TW; Lin YF; Huang CY; Lin YC; Han BC; Hsueh YM
Toxicol Appl Pharmacol; 2014 Sep; 279(2):95-102. PubMed ID: 24907556
[TBL] [Abstract][Full Text] [Related]
19. Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients.
Supic G; Jovic N; Zeljic K; Kozomara R; Magic Z
Oral Oncol; 2012 Nov; 48(11):1171-7. PubMed ID: 22818823
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
Jin Q; Hemminki K; Enquist K; Lenner P; Grzybowska E; Klaes R; Henriksson R; Chen B; Pamula J; Pekala W; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Hallmans G; Försti A
Clin Cancer Res; 2005 May; 11(10):3647-53. PubMed ID: 15897560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
